(344 days)
Not Found
No
The description focuses on photoelectronic colorimetry and cold light source technology, with no mention of AI, ML, or image processing. The performance studies compare results to predicate devices using standard statistical methods, not AI/ML specific metrics.
No.
The device is an in vitro diagnostic device (IVDD) used for screening and assisting diagnosis of various health conditions, not for therapy.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device is "intended for prescription, in vitro diagnostic use" and "is intended for use in screening at-risk patients to assist diagnosis". The "Device Description" also labels them as "in vitro-diagnostic devices (IVDD)".
No
The device description explicitly states it is a "semi-automatic photoelectronic colorimeter" and a "bench top instrument," indicating it is a physical hardware device, not software only.
Yes, this device is an IVD (In Vitro Diagnostic).
The "Intended Use / Indications for Use" section explicitly states: "ARJ Medical URITEST 50 urine analyzer is a semi-automated, bench top instrument which is intended for prescription, in vitro diagnostic use with the URITEST 10 Urinalysis Reagent Strips manufactured by ARI Medical, Inc."
The "Device Description" section also states: "The Uritest 50 and Uritest 500 urine analyzers are in vitro-diagnostic devices (IVDD)."
N/A
Intended Use / Indications for Use
ARJ Medical URITEST 50 urine analyzer is a semi-automated, bench top instrument which is intended for prescription, in vitro diagnostic use with the URITEST 10 Urinalysis Reagent Strips manufactured by ARI Medical, Inc. This system performs qualitative detection of Nitrites and semi-quantitative detection of Urobilinogen, Bilirubin, Ketone, Blood, Protein, Leukocytes, Specific gravity and pH. The instrument uses the accompanying check strip for daily calibration.
ARI Medical URITEST 50 Urinalysis Analyzer is for use in professional near patient (point-of-care) facilities and centralized laboratory. The analyzer is intended for use in screening at-risk patients to assist diagnosis in the following areas:
- Kidney Function Urinary Tract infections Carbohydrate metabolism Liver Function Acid-Base balance Urine Concentration
ARJ Medical Uritest 500 urine analyzer is a semi-automated, bench top instrument which is intended for prescription, in vitro diagnostic use with the URITEST 10 Urinalysis Reagent Strips manufactured by ARJ Medical, Inc. This system performs qualitative detection of Nitrites and semi-quantitative detection of Urobilinogen, Bilirubin, Ketone, Blood, Protein, Leukocytes, Glucose, Specific gravity and pH. The instrument uses the accompanying check strip for daily calibration.
ARJ Medical URITEST 500 Urinalysis Analyzer is for use in professional near patient (point-of-care) facilities and centralized laboratory. The analyzer is intended for use in screening at-risk patients to assist diagnosis in the following areas:
Kidney Function Urinary Tract infections Carbohydrate metabolism Liver Function Acid-Base balance Urine Concentration
Product codes (comma separated list FDA assigned to the subject device)
JIO, JIL, CDM, JJB, JIN, JIR, JMT, LJX, CEN, KSL, KQO
Device Description
ARJ Medical Uritest 50 and Uritest 500 urine analyzer is a kind of semi-automatic photoelectronic colorimeter that can be used together with the Uritest 10 Urine Reagent Strips manufactured by ARJ Medical, Inc. Adopting the advanced "super-high luminosity cold light source reflection determination" technology, the "high luminosity cold light source" has two main advantages.
- (1) the usable life of a cold light is longer than the normal light source
- (2) the temperature of the normal light source will increase during testing, affecting the test result vs the temperature of the cold light source is constant not potentially affecting the result.
It can finish the tests on 10 kinds of biochemical components in urine within 30 seconds, and it also can revise the affects toward the test result which is caused by ambient temperature, ambient light, acid-base scale and abnormally colored sample. The Uritest 50 and Uritest 500 urine analyzers are in vitro-diagnostic devices (IVDD).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
professional near patient (point-of-care) facilities and centralized laboratory.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
The performance of URITEST 50 and URITEST 500 Urinalysis Analyzers were studied in (3) hospital laboratory settings. Urinalysis strips were read instrumentally using the Uritest 50 and Uritest 500 Urinalysis Analyzer. All samples were natural samples. There were 520 natural negative samples and 381 positive natural urine samples tested at 3 sites combined. Samples were unaltered. For each of the sites the total number of positive and negative samples were: No.1 Clinical Hospital of Jilin University (135 Negative, 110 Positive), China-Japan Friendship Hospital of Jilin University (180 Negative, 140 Positive), The People's Hospital of Jilin Province (205 Negative, 131 Positive).
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The performance of URITEST 50 and URITEST 500 Urinalysis Analyzers were studied in (3) hospital laboratory settings. Urinalysis strips were read instrumentally using the Uritest 50 and Uritest 500 Urinalysis Analyzer. All samples were natural samples. There were 520 natural negative samples and 381 positive natural urine samples tested at 3 sites combined. Samples were unaltered. For each of the sites the total number of positive and negative samples were: No.1 Clinical Hospital of Jilin University (135 Negative, 110 Positive), China-Japan Friendship Hospital of Jilin University (180 Negative, 140 Positive), The People's Hospital of Jilin Province (205 Negative, 131 Positive). The results were compared to results obtained from Bayer Clinitek 50 and Clinitek 500 Urine Analyzers. The studies demonstrated that professional users in centralized and point-of-care (POC) hospital, clinical and doctor's office setting can obtain valid urinalysis test results.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.2900 Automated urinalysis system.
(a)
Identification. An automated urinalysis system is a device intended to measure certain of the physical properties and chemical constituents of urine by procedures that duplicate manual urinalysis systems. This device is used in conjunction with certain materials to measure a variety of urinary analytes.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
0
KC091472
URITEST 50 and URITEST 500 Urine Analyzer 510(K) Summar
| Prepared: | April 26, 2010 |
|---|---|
| Submitter: | ARJ Medical, Inc |
| Address: | 209 State Street |
| Oldsmar, FL 34677 | |
| Contact Person: | Aaron Behar |
| ARJ Medical, Inc | |
| 209 State Street | |
| Oldsmar, FL 34677 | |
| Tel: (813) 855-1557 | |
| Fax: (813) 854-2340 | |
| Trade Proprietary Name: | |
| APR 2 7 2010 |
URITEST 50 and URITEST 500 Urine Analyzers
Common/Usual Name:
Automated Urinalysis Analyzer (KQO)
Classification Names:
Automated Urinalysis System (21 CFR 862.2900) Urinary glucose (non-quantitative) test system (21 CFR 862.1340) - Class II Urinary bilirubin and its conjugates (non-quantitative) test system (21 CFR 862.1115) — Class I Ketones (non-quantitative) test system (21 CFR 862.1435) – Class I Specific Gravity test (not classified in 21 CFR 862 or 864) - proposed Class I Occult blood test (21 CFR 864.6550) - Class II Urinary pH (non-quantitative) test system (21 CFR 862.1550) – Class I Urinary protein or albumin (non-quantitative) test system (21 CFR 862.1645) – Class I Urinary urobilinogen (non-quantitative) test system (21 CFR 862.1785) - Class I Nitrite (non-quantitative) test system (21 CFR 862.1510) - Class I Leukocyte peroxidase test (21 CFR 864.7675) - Class I
Legally marketed devices which we are claiming equivalence:
ARJ Medical Uritest 10 Reagent Strips in conjunction with Bayer Clinitek 50 and 500 - K052719
Device Description:
1
ARJ Medical Uritest 50 and Uritest 500 urine analyzer is a kind of semi-automatic photoelectronic colorimeter that can be used together with the Uritest 10 Urine Reagent Strips manufactured by ARJ Medical, Inc. Adopting the advanced "super-high luminosity cold light source reflection determination" technology, the "high luminosity cold light source" has two main advantages.
- (1) the usable life of a cold light is longer than the normal light source
- (2) the temperature of the normal light source will increase during testing, affecting the test result vs the temperature of the cold light source is constant not potentially affecting the result.
It can finish the tests on 10 kinds of biochemical components in urine within 30 seconds, and it also can revise the affects toward the test result which is caused by ambient temperature, ambient light, acid-base scale and abnormally colored sample. The Uritest 50 and Uritest 500 urine analyzers are in vitro-diagnostic devices (IVDD).
Intended Use:
The Uritest 50 and Uritest 500 provide a qualitative result for Nitrites and a semi-quantitative result for Urobilinogen, Bilirubin, Ketone, Blood, Protein, Leucocytes, Glucose, Specific gravity, and pH of urine specimen according to the color change caused by the interaction between the reagent areas and the biochemical components in urine.
Assessment of Performance:
The performance of URITEST 50 and URITEST 500 Urinalysis Analyzers were studied in (3) hospital laboratory settings. Urinalysis strips were read instrumentally using the Uritest 50 and Uritest 500 Urinalysis Analyzer. All samples were natural samples. There were 520 natural negative samples and 381 positive natural urine samples tested at 3 sites combined. Samples were unaltered. For each of the sites the total number of positive and negative samples were: No.1 Clinical Hospital of Jilin University (135 Negative, 110 Positive), China-Japan Friendship Hospital of Jilin University (180 Negative, 140 Positive), The People's Hospital of Jilin Province (205 Negative, 131 Positive). The results were compared to results obtained from Bayer Clinitek 50 and Clinitek 500 Urine Analyzers. The studies demonstrated that professional users in centralized and point-of-care (POC) hospital, clinical and doctor's office setting can obtain valid urinalysis test results.
Conclusion:
The URITEST 50 and URITEST 500 Urinalysis Analyzer provide 10 reagent tests of urinalysis that are similar in composition and performance to reagent tests currently provided by devices on the U.S. market. The URITEST 50 and URITEST 500 Urinalysis Analyzer is suitable for use in point-of-care (POC), hospital, clinical and doctor's office setting. ARJ Medical studies showed that the URITEST 50 and URITEST 500 Urinalysis Analyzer provide test results consistent with laboratory methods and performance comparable to that of the Bayer Clinitek 50 Urine Analyzer and the Bayer Clinitek 500 in point-of-care (POC), hospital, clinical and doctor's office setting.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an emblem featuring a stylized eagle with outstretched wings.
ARJ Medical, Inc. c/o Mr. Aaron Behar Vice President 209 State Street Oldsmar, FL 34677
. "
Food & Drug Administration 10903 New Hampshire Avenue Building 66 Silver Spring, MD 20993
Re: K091472 APR 2 7 2010
Trade Name: Uritest 50 and Uritest 500 Urine Analyzers Regulation Number: 21 CFR §864.6550 Regulation Name: Occult blood test. Regulatory Class: Class II Product Codes: JIO, JIL, CDM, JJB, JIN, JIR, JMT, LJX, CEN, KSL, KQO Dated: March 31, 2010 Received: March 31, 2010
Dear Mr. Behar:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
3
Page 2
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or ( 301 ) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
AC
Courtney C. Harper, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE
510(K) Number: K091472
Device Name: URITEST 50 Urine Analyzer
Indications for Use:
ARJ Medical URITEST 50 urine analyzer is a semi-automated, bench top instrument which is intended for prescription, in vitro diagnostic use with the URITEST 10 Urinalysis Reagent Strips manufactured by ARI Medical, Inc. This system performs qualitative detection of Nitrites and semi-quantitative detection of Urobilinogen, Bilirubin, Ketone, Blood, Protein, Leukocytes, Specific gravity and pH. The instrument uses the accompanying check strip for daily calibration.
ARI Medical URITEST 50 Urinalysis Analyzer is for use in professional near patient (point-of-care) facilities and centralized laboratory. The analyzer is intended for use in screening at-risk patients to assist diagnosis in the following areas:
- Kidney Function Urinary Tract infections Carbohydrate metabolism Liver Function Acid-Base balance Urine Concentration
Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Carol C. Benson
Sign-Off
of In Vitro Diagnostic Device inn and S
Page 1 of 2
5
INDICATIONS FOR USE
510(K) Number: K091472
Device Name: URITEST 500 Urine Analyzer
Indications for Use:
ARJ Medical Uritest 500 urine analyzer is a semi-automated, bench top instrument which is intended for prescription, in vitro diagnostic use with the URITEST 10 Urinalysis Reagent Strips manufactured by ARJ Medical, Inc. This system performs qualitative detection of Nitrites and semi-quantitative detection of Urobilinogen, Bilirubin, Ketone, Blood, Protein, Leukocytes, Glucose, Specific gravity and pH. The instrument uses the accompanying check strip for daily calibration.
ARJ Medical URITEST 500 Urinalysis Analyzer is for use in professional near patient (point-of-care) facilities and centralized laboratory. The analyzer is intended for use in screening at-risk patients to assist diagnosis in the following areas:
Kidney Function Urinary Tract infections Carbohydrate metabolism Liver Function Acid-Base balance Urine Concentration
Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Carol C. Benen
Page 2 of 2